Inside Drug Pricing - 06/10/2019

Pharma Open To Paying Catastrophic Costs If Donut Hole Discounts Axed

By Rachel Cohrs John Wilkerson / June 6, 2019 at 6:18 PM
Lobbyists for brand drug makers have told Senate Finance Committee staff they’re open to paying a share of seniors’ catastrophic Medicare Part D drug costs in exchange for capping seniors’ out-of-pocket costs and relieving drug makers of the 70% discounts they currently must pay for drugs that beneficiaries take while in the donut hole, according to sources close to the negotiations. Finance members are using a Part D reform proposal by the American Action Forum as a template for changes...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.